Brief: Neubase Therapeutics Board Terminated Employment Of Dietrich Stephan As CEO
17/01/2024 11:21
Jan 17 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS INC: ON JAN 12, BOARD TERMINATED
EMPLOYMENT
OF DIETRICH A. STEPHAN, PH.D. AS CHIEF EXECUTIVE OFFICER OF
COMPANY, WITHOUT CAUSE
* NEUBASE THERAPEUTICS- APPOINTED TODD P. BRANNING, WHO HAS
SERVED AS COMPANY'S CFO SINCE JANUARY 2022, AS INTERIM CEO
* NEUBASE THERAPEUTICS INC: DIETRICH A. STEPHAN IS EXPECTED
TO
CONTINUE TO SERVE ON BOARD
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet